The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence

The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections Pub Date : 2022-06-01 DOI:10.1016/j.jinf.2022.06.004

L. Sang, B. Cheng, Yuheng Yu, Yin Xi, Yun Wang, Bingdong Fan, Jijie Li, Jingtao Dai, G. Gan, Shijun Tong, B. Sun, Xiaojing Qi, W. Liang, J. He, Nanshan Zhong

引用次数: 0

查看原文本刊更多论文

IBI314对SARS-CoV-2 δ型和组粒型变体的有效性和安全性:首次人体证据

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections

自引率

0.00%

发文量